The Hemophilia Treatment Center at Oregon Health & Science University (OHSU) is one of twelve regional grantees nationwide who receive grant funding from the federal Maternal and Child Health Bureau (MCHB) and the Centers for Disease Control (CDC). Funding received from MCHB directs Hemophilia Centers to provide comprehensive care for bleeding and clotting disorders, including diagnosis and treatment. The MCHB supports inter-disciplinary care teams and promotes active consumer participation in all aspects of care provided by the Hemophilia Center.
As the regional core center, the Hemophilia Treatment Center collaborates with the following centers throughout the Northwest:
- The Hemophilia Program, at Puget Sound Blood Center in Seattle, Washington
- The Hematology Clinic, at Seattle Children’s Hospital in Seattle, Washington
- The Hemophilia Program, at Providence Sacred Heart Children's Hospital Pediatric Oncology Center in Spokane, Washington
- The Idaho Regional Hemophilia Center, at Mountain States Tumor Institute at St. Luke's Regional Medical Center in Boise, Idaho
- The Alaska Hemophilia Treatment Center (of the Alaska Hemophilia Association), at Providence Alaska Regional Medical Center in Anchorage, Alaska
The Hemophilia Treatment Center serves people with hemophilia A (factor VIII deficiency), hemophilia B (factor IX deficiency), von Willebrand's disease, and other hereditary bleeding and clotting disorders in Oregon and southwest Washington.